药量计学建模和模拟,以协助在狗中优化法诺巴比特的剂量
Silvana Alvariza1, Manuel Ibarra2, Natalia Guevara2
1Department of Clinical and Veterinary Hospital, Faculty of Veterinary, Pharmacology and Therapeutics Unit, Universidad de la República, Montevideo, Uruguay.
Frontiers in veterinary science
|September 19, 2025
概括
这项研究开发了狗体内巴比塔尔的种群药动力学模型. 该模型考虑了年龄和体重,支持精确的剂量,以改善犬治疗结果.
科学领域:
- 兽医药理学 兽医药理学
- 药理动力学 药理动力学
- 狗医疗 狗医疗 狗医疗
背景情况:
- 芬诺巴比他 (PB) 是一线治疗犬的药物.
- 它狭窄的治疗指数和显著的个体间变异性需要仔细的剂量和监测.
- 需要个性化剂量策略来优化疗效并最大限度地降低毒性.
研究的目的:
- 开发和验证狗中PB的种群药理动力学 (popPK) 模型.
- 在临床实践中支持基于模型的精确剂量 (MIPD).
- 根据患者特定的因素,实现个性化的PB剂量.
主要方法:
- 使用非线性混合效应 (NLME) 技术开发了一个popPK模型,使用100只狗的121个血清样本.
- 外部验证使用了来自50只狗的53个样本.
- 共变量分析包括年龄和体重 (WT);模型性能使用适合性和视觉预测检查进行评估.
主要成果:
- 一个具有自诱导性清除的单间模型最好地描述了PB的药理动力学.
- 体重和年龄是影响明显清除的重要共变量.
- 该模型准确地预测了外部数据集中的PB度.
结论:
- 经过验证的popPK模型通过考虑年龄和体重的变化,促进了对狗的个性化PB剂量.
- 这种方法支持MIPD在兽医实践中的实施.
- 优化剂量方案可以改善治疗结果,并减少的狗的毒性.
相关概念视频
Pharmacokinetic Models: Comparison and Selection Criterion
338
Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
338
Dosage Regimens: Partial Pharmacokinetic Parameters
155
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
155
Pharmacokinetic Models: Overview
1.9K
Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
1.9K
Analysis of Population Pharmacokinetic Data
682
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
682
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
242
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
242
Model Approaches for Pharmacokinetic Data: Compartment Models
526
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Two primary types of compartment models are recognized: mammillary and catenary. The more...
526


